Dievini Hopp BioTech Holding GmbH & Co. KG

https://www.dievini.com

	Start	2009-02-18 existent
	Group	HOPP Group (family of Dietmar Hopp)
	Industry	venture capital
	Industry 2	BIOTECH
	Person	Hothum, Mathias (Hopp Group 201304 Managing Director of Dievini Hopp Bio Tech Holding)
	Person 2	Hopp, Dietmar (SAP)

	Region	Walldorf
	Country	Germany
	Street	57 Johann-Jakob-Astor-Str.
	City	69190 Walldorf
	Tel	+49-6202-204-8945
		Address record changed: 2022-09-17

Basic data	Employees	n. a.


		Record changed: 2023-12-30

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for HOPP Group (family of Dietmar Hopp)

[1] CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA....
[2] dievini Hopp BioTech holding GmbH & Co. KG. (3/15/20). "Press Release: dievini nimmt Stellung zu Presseveröffentlichungen über ihre Beteiligungsgesellschaft". Walldorf....
[3] CureVac AG. (5/8/18). "Press Release: CureVac Announces New Management Structure. Founder Ingmar Hoerr to Transition to Chairman role; Daniel Menichella to Become CEO". Tübingen....
[4] Immatics Biotechnologies GmbH. (10/4/17). "Press Release: Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies". Tübingen & Houston, TX....
[5] G1 Therapeutics, Inc.. (6/17/14). "Press Release: G1 Therapeutics Completes Leadership Team with Appointment of Raj Malik, MD, Chief Medical Officer and Greg Mossinghoff, Chief Business Officer". Research Triangle Park, NC....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]